Lozol
NDC Package 0075-0700-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lozol is a . Marketed by Sanofi-aventis U.s. Llc (formerly Known As Aventis Pharmaceuticals Inc.), this product is identified by NDC 0075-0700 and is authorized under FDA application NDA018538.

Identification & Billing

NDC Package Code
0075-0700-00
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
00075070000

Clinical Specifications

Proprietary Name
Lozol
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sanofi-aventis U.s. Llc (formerly Known As Aventis Pharmaceuticals Inc.)
FDA Application #
NDA018538
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-06-1983
End Marketing Date
10-31-2007
Listing Expiration
10-31-2007
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0075-0700). Click a package code to view its specific billing and regulatory data.

1000 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0075-0700-00 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Lozol, labeled by Sanofi-aventis U.s. Llc (formerly Known As Aventis Pharmaceuticals Inc.). This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sanofi-aventis U.s. Llc (formerly Known As Aventis Pharmaceuticals Inc.) on July 06, 1983. The current certification is valid through October 31, 2007.

How is this Sanofi-aventis U.s. Llc (formerly Known As Aventis Pharmaceuticals Inc.) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00075070000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0075-0700-00
11-Digit CMS (5-4-2)
00075-0700-00

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.